Sydney-based biotech giant Biotron Ltd claims it has developed a new anti-HIV compound capable of acting against strains of HIV that can't be treated with existing drugs, reports Asia Pulse

The company says that its "Virion" compound can open a new treatment for AIDS patients

The Food and Drug Administration (FDA) has proposed a "Drug Watch" Web page that would list drug safety concerns that are being evaluated by the agency.

The drug industry's U.S. lobbying group said the information the FDA wants to publicize "is too vague and preliminary to be of any value in making informed treatment and prescribing decisions

What was once thought to be necessary tools in the fight against an epidemic have now gone to waste.

Hundreds of thousands of flu shots ordered from Europe last year amid fears of a nationwide shortage have now expired and may go to waste, potentially costing taxpayers millions of dollars, officials say Wednesday in an Associated Press report

Agreement between Teva Pharmaceutical Industries Ltd. and its rival, Ivax Corp. was announced Monday.

Teva has agreed to buy Ivax Corp. for $7.4 billion USD

Australian drug manufacturer, Amrad, wins a U.S. patent for therapeutic antibodies used to treat asthma and other respiratory diseases.

According to an Asia Pulse report, the Melbourne-based biotech company signed a joint collaboration agreement with U.S.-based pharmaceutical Merck at $112 million, excluding royalties on product sales